The Great Oil Sale! Russia Sells Heavily Discounted Crude to India as Sanctions Bite
Russian President Vladimir Putin is offering substantial discounts on oil sales to India, as crippling Western sanctions take their toll
Read more
Month: March 2022
Hycroft Mining: BMO Indicates Company Still Doesn’t Have Sufficient Capital For Mine Restart
On the evening of March 25, Hycroft Mining Holding Corporation (NASDAQ: HYMC) announced it had closed its recently announced at-the-market
Read more
Applebee’s Executive Gets Flak After Excitedly Outlining How To Take Advantage Of The Poor In An Email
Earlier this month, Wayne Pankratz, an executive director of operations for American Franchise Capital, which owns 50 Applebee’s in the
Read more
U.S. Imposes Higher Penalties on Automakers for Not Meeting Fleetwide MPG Standards, Tesla To Benefit
U.S. President Biden continues to go “all-in” on building up the electric vehicle (EV) industry. On March 24, the National Highway
Read more
MJardin: A Bridging Finance Debt Warehouse
The Deep Dive has identified MJardin Group (CSE:MJAR) as one of three Canadian cannabis companies that insolvent commercial lender Bridging
Read more
Sri Lanka Suffers Rolling Blackouts Amid Worsening Economic Crisis
Sri Lankan citizens were left without power for most of the day on Wednesday, as the country lapses into a
Read more
SPAC Queen’s Gambit Growth Capital Secures Shareholder Approval Of Merger With Mass Transit Platform Swvl
Special purpose acquisition company Queen’s Gambit Growth Capital (Nasdaq: GMBT) announced on Wednesday that it has secured its shareholders’ approval
Read more
Pond Tech: Converting CO2 Into Algae – The Daily Dive
Joining us for the first time on the Daily Dive today is Grant Smith, CEO of Pond Technologies (TSXV: POND).
Read more
Galaxy Digital Posts $1.71 Billion Net Income For 2021, Still Awaits SEC On Nasdaq Listing
Galaxy Digital Holdings Ltd. (TSX: GLXY) released today its Q4 and full-year 2021 financial results, which saw the company posting
Read more
FDA Puts CytoDyn Clinical Trials For HIV, COVID-19 On Hold
CytoDyn Inc. (OTCQB: CYDY) reported on Wednesday that its current trials for investigational drug leronlimab will be put on partial
Read more